查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1545523

全球数位 PCR 市场

Digital PCRs
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球数位 PCR 市场预计将达到 3.712 亿美元

预计 2023 年全球数位 PCR 市场规模为 2.172 亿美元，预计到 2030 年将达到 3.712 亿美元，2023 年至 2030 年复合年增长率为 8.0%。基础研究应用是本报告分析的细分市场之一，预计复合年增长率为 8.0%，到分析期结束时将达到 1.507 亿美元。分析期间，临床诊断应用领域的复合年增长率预计为8.5%。

美国市场预估为5,980万美元，中国预期复合年增长率为7.3%

预计 2023 年美国数位 PCR 市场规模将达到 5,980 万美元。中国作为全球第二大经济体，预计2030年市场规模将达5,670万美元，2023-2030年分析期间复合年增长率为7.3%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 7.3% 和 6.5%。在欧洲，德国的复合年增长率预计约为 6.4%。

全球数位PCR市场趋势及驱动因素总结

什么是数位 PCR？

数位 PCR (dPCR) 是一种高度准确且灵敏的分子技术，用于定量和扩增 DNA 或 RNA。此方法将样品分成许多单独的反应。 PCR 扩增后，对每个分区进行分析以确定目标序列是否存在，从而比传统 PCR 方法进行更准确的定量。数位 PCR 提供绝对定量，无需参考标准或内部对照，显着提高检测低丰度标靶、评估基因表现量和分析遗传变异的置信度。这项技术在临床诊断、个人化医疗和环境生物学中特别有价值，因为准确的测量非常重要。

科技进步如何提升数位 PCR 的能力？

数位 PCR 的最新技术进步包括流体动态、微流体和软体分析的改进，提高了这些系统的准确性、易用性和吞吐量。液滴数位 PCR (ddPCR) 和基于晶片的 dPCR 等创新彻底改变了该领域，透过增加分析的分区数量提供更高的灵敏度和准确性。这些进步使研究人员能够以前所未有的精确度检测罕见的 DNA 目标，例如血液样本中低浓度的肿瘤 DNA。此外，自动化和即时资料分析软体的整合减少了人为错误的可能性并简化了工作流程，使数位 PCR 成为高通量环境中常规使用的强大工具。

数位 PCR 技术正在推动哪些应用？

数位 PCR 在基础研究以外的各种应用中变得越来越重要。在临床诊断中，它用于早期检测癌症突变和感染疾病、监测微小残留疾病并追踪治疗效果，这可以直接影响患者的治疗计划和结果。在环境监测领域，dPCR 可以检测土壤和水样本中的低水平病原体和基因改造作物。此外，在快速发展的液态切片领域，dPCR 可以透过检测和量化循环肿瘤 DNA 来帮助非侵入性癌症诊断，为早期诊断、预后预测和疾病监测提供强大的工具。每个应用都受益于 dPCR 的高灵敏度和精确度，推动其融入这些重要的研究和应用领域。

什么将推动数位PCR市场的成长？

数位 PCR 市场的成长受到多种因素的推动，包括对需要强大定量技术的精确分子诊断和个人化医疗的需求不断增长。遗传疾病和癌症盛行率的上升，加上液态切片的认识和临床应用的不断提高，将进一步推动对数位 PCR 技术的需求。提高 dPCR 装置效率并降低成本的技术创新也有助于市场扩张。此外，dPCR在食品安全、环境监测、农业生物学等领域的应用范围不断扩大，凸显了其多功能性和有效性，吸引了各领域的投资。这些因素，加上数位 PCR 系统的不断改进和对精确诊断的日益重视，确保了 dPCR 市场的持续扩大，反映了分子生物学和临床诊断的未来重要性。

受访企业范例（共46家）

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP11555

Global Digital PCRs Market to Reach US$371.2 Million by 2030

The global market for Digital PCRs estimated at US$217.2 Million in the year 2023, is expected to reach US$371.2 Million by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Basic Research Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$150.7 Million by the end of the analysis period. Growth in the Clinical Diagnostics Application segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$59.8 Million While China is Forecast to Grow at 7.3% CAGR

The Digital PCRs market in the U.S. is estimated at US$59.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$56.7 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Digital PCRs Market - Key Trends and Drivers Summarized

What Is Digital PCR and Why Is It a Game-Changer in Molecular Biology?

Digital PCR (dPCR) is a highly precise and sensitive molecular technique used to quantify and amplify DNA or RNA. This method partitions a sample into many individual reactions. After PCR amplification, each partition is analyzed to determine the presence or absence of the target sequence, allowing for more accurate quantification than traditional PCR methods. Digital PCR provides absolute quantification without the need for reference standards or internal controls, which significantly enhances its reliability for detecting low-abundance targets, assessing gene expression levels, and analyzing genetic variations. This technology is particularly valuable in clinical diagnostics, personalized medicine, and environmental biology, where precise measurements are crucial.

How Are Technological Advancements Refining Digital PCR Capabilities?

Recent technological advancements in digital PCR include improvements in fluid dynamics, microfluidics, and software analytics, which enhance the accuracy, usability, and throughput of these systems. Innovations such as droplet digital PCR (ddPCR) and chip-based dPCR have revolutionized the field by increasing the number of partitions analyzed, thereby providing greater sensitivity and precision. These advancements allow researchers to detect rare DNA targets, such as low-abundance tumor DNA in blood samples, with unprecedented accuracy. Furthermore, the integration of automation and real-time data analysis software reduces the potential for human error and streamlines the workflow, making digital PCR a robust tool for routine use in high-throughput settings.

What Applications Are Driven by Digital PCR Technology?

Digital PCR is becoming increasingly crucial across various applications beyond basic research. In clinical diagnostics, it is used for early detection of cancer mutations and infectious diseases, monitoring minimal residual disease, and tracking treatment efficacy, which can directly influence patient treatment plans and outcomes. In the field of environmental monitoring, dPCR enables the detection of low-levels of pathogens or GMOs in soil and water samples. Additionally, in the burgeoning field of liquid biopsy, dPCR helps in non-invasive cancer diagnostics by detecting and quantifying circulating tumor DNA, offering a powerful tool for early diagnosis, prognosis, and disease monitoring. Each application benefits from dPCR’s high sensitivity and precision, driving its integration into these critical areas of study and application.

What Drives the Growth in the Digital PCR Market?

The growth in the digital PCR market is driven by several factors, including the increasing demand for precise molecular diagnostics and personalized medicine, which require robust quantitative techniques. The rising prevalence of genetic disorders and cancer, coupled with growing awareness and clinical adoption of liquid biopsies, further fuels the demand for digital PCR technology. Technological innovations that enhance the efficiency and reduce the cost of dPCR setups also contribute to market expansion. Additionally, the broadening applications of dPCR in food safety, environmental monitoring, and agricultural biology emphasize its versatility and effectiveness, attracting investment from various sectors. These factors, combined with the ongoing improvements in digital PCR systems and a growing emphasis on precision diagnostics, ensure that the market for dPCR will continue to expand, reflecting its critical importance in the future of molecular biology and clinical diagnostics.

Select Competitors (Total 46 Featured) -

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Digital PCRs - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine Propels Adoption of Digital PCRs
    • Increasing Use of Digital PCR in Cancer Diagnostics Expands Market Opportunities
    • Expanding Applications of Digital PCR in Infectious Disease Testing Sets the Stage for Market Growth
    • Rising Adoption of Digital PCRs in Liquid Biopsy Technologies Drives Market Expansion
    • Increasing Use of Digital PCRs in Agricultural Biotechnology Bodes Well for Market Growth
    • Growing Focus on Non-Invasive Prenatal Testing (NIPT) Spurs Adoption of Digital PCRs
    • Growing Use of Digital PCR in Environmental Testing Expands Addressable Market
    • Expansion of Digital PCR in Food Safety Testing Generates Market Opportunities
    • Rising Prevalence of Genetic Disorders Sets the Stage for Growth in Digital PCR Market
    • Development of Portable Digital PCR Devices Bodes Well for Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Basic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Digital PCRs Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION